Cancer Biology & Therapy

Papers
(The H4-Index of Cancer Biology & Therapy is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Evaluating massage therapy for radiation-induced fibrosis in rats: preliminary findings and palpation results86
CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells76
Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article64
Correction62
Tripartite motif-containing protein 50 suppresses triple-negative breast cancer progression by regulating the epithelial–mesenchymal transition54
A novel biochip-based liquid biopsy for extracellular vesicle RNA detection in prostate cancer47
Advances in natural killer cell immunotherapy for hematologic malignancies43
Immunotherapy resistance in solid tumors: mechanisms and potential solutions41
Dual role of CXCL10 in cancer progression: implications for immunotherapy and targeted treatment‎40
A comparison of cell death pathways in three different kinds of human lung cancer cell lines following hematoporphyrin derivative-mediated photodynamic therapy39
Molecular profiles of different PD-L1 expression in patients with esophageal squamous cell carcinoma37
Epigenetic silencing L3MBTL4 sensitizes esophageal cancer to DNA-PKcs inhibitor37
DDX24 regulates the chemosensitivity of hepatocellular carcinoma to sorafenib via mediating the expression of SNORA1837
Advancements in exosome-based cancer diagnosis: from chipsets to nano vaccine35
miRNA-660-3p inhibits malignancy in glioblastoma via negative regulation of APOC1-TGFβ2 signaling pathway33
GdX inhibits the occurrence and progression of breast cancer by negatively modulating the activity of STAT332
Protein lactylation: molecular mechanisms underlying lactate-driven tumorigenesis and cancer progression28
MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer28
Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer27
SATB1 mediated tumor colonization and β-catenin nuclear localization are associated with colorectal cancer progression27
USP7 overexpression prevents the progression of clear cell renal cell carcinoma by enhancing pyroptosis via TRIP12 deubiquitination26
Silencing ZIC5 suppresses glycolysis and promotes disulfidptosis in lung adenocarcinoma cells26
The MYBL2-GTSE1 axis promotes laryngeal squamous cell carcinoma progression by regulating PI3K/AKT-dependent glycolytic reprogramming26
Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancer24
Evaluating carboplatin and PARP inhibitor combination efficacy using high-grade serous carcinoma spheroids and organoids24
Nucleo-cytoplasmic shuttling of 14-3-3 epsilon carrying hnRNP C promotes autophagy24
0.062156915664673